Researchers have used a chemical compound to light up treatment-resistant cancers on imaging scans, in a breakthrough that ...

The FDA delays Johnson & Johnson's SC amivantamab approval for NSCLC over facility inspection issues, unrelated to product ...

New findings from the NC Department of Health and Human Services reveal high radon levels detected in 77 out of 100 North ...

The FDA issues a complete response letter to JNJ's BLA seeking approval for the subcutaneous formulation of Rybrevant in EGFR ...

Researchers have used a chemical compound to light up treatment-resistant cancers on imaging scans, in a breakthrough that could help medical professionals better target and treat cancer.

The Global Cancer Vaccines Market is experiencing a significant growth phase, with its valuation rising from $4,188 million in 2019 to an expected $7,303 million by 2027. This report aims to provide a ...

A promising breakthrough in the fight against cancer emerges from Russia. The cancer vaccine developed by the Gamaleya Center ...

Johnson & Johnson (JNJ) injectable cancer drug Rybrevant developed with Halozyme (HALO) is declined by the FDA due to ...

After years of fighting for full reparations, the community of Piquiá de Baixo in the Brazilian state of Maranhão secured ...

LUND, SE / ACCESSWIRE / December 18, 2024 / Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F) Spago Nanomedical AB (publ) today ...

Researchers have lamented how daily bread consumption is becoming a poison despite National Agency for Food and Drug ...

The FastGlioma tool could enable rapid and accurate detection of microscopic tumour infiltration, improving the success of ...